Cite
A novel pathogenic CRB1 variant presenting as Leber Congenital Amaurosis 8 and evaluation of gene editing feasibility.
MLA
Sylla, Mohamed M., et al. “A Novel Pathogenic CRB1 Variant Presenting as Leber Congenital Amaurosis 8 and Evaluation of Gene Editing Feasibility.” Documenta Ophthalmologica. Advances in Ophthalmology, vol. 147, no. 3, Dec. 2023, pp. 217–24. EBSCOhost, https://doi.org/10.1007/s10633-023-09951-w.
APA
Sylla, M. M., Kolesinkova, M., da Costa, B. L., Maumenee, I. H., Tsang, S. H., & Quinn, P. M. J. (2023). A novel pathogenic CRB1 variant presenting as Leber Congenital Amaurosis 8 and evaluation of gene editing feasibility. Documenta Ophthalmologica. Advances in Ophthalmology, 147(3), 217–224. https://doi.org/10.1007/s10633-023-09951-w
Chicago
Sylla, Mohamed M, Masha Kolesinkova, Bruna Lopes da Costa, Irene H Maumenee, Stephen H Tsang, and Peter M J Quinn. 2023. “A Novel Pathogenic CRB1 Variant Presenting as Leber Congenital Amaurosis 8 and Evaluation of Gene Editing Feasibility.” Documenta Ophthalmologica. Advances in Ophthalmology 147 (3): 217–24. doi:10.1007/s10633-023-09951-w.